Scientific Affairs, NuProbe
BIOGRAPHY
Speaker
Event Date & Time
Date: December 8, 2022
Time: 9:00am (PST), 12:00pm (EST), 6:00pm (CET)
Abstract
Liquid biopsy enables non-invasive testing and monitoring in oncology, but also comes with unique challenges. In this webinar we will discuss the current state of liquid biopsies and introduce one of our novel research technologies, Blocker Displacement Amplification (BDA), which can improve liquid biopsies. We also highlight applications of BDA in non-invasive longitudinal monitoring.
Learning Objectives
- Discuss the current state, advantages, and limitations of non-invasive liquid biopsies in oncology.
- Introduce Blocker Displacement Amplification (BDA), a rare allele enrichment technology with the potential to improve mutation detection from liquid biopsy.
- Highlight research applications of BDA in non-invasive longitudinal monitoring.
*NuProbe’s technologies are for Research Use Only. Not for use in diagnostic procedures.
Webinars will be available for unlimited on-demand viewing after live event.
Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...